Roche
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Switzerland · 10K+ Employees
View Company Info for Free
Overview
Headquarters
Grenzacherstrasse 124, Basel, Basel-City...Phone Number
+41616881111Website
www.roche.comRevenue
$79.8 BillionStock Symbol
ROIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
2
4
3
3
2
1
About Roche
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's pharmaceutical division focuses on developing and manufacturing prescription medicines across major therapeutic areas including oncology, immunology, infectious diseases, ophthalmology, and diseases of the central nervous system. The diagnostics division provides a comprehensive range of products and services for early detection, prevention, diagnosis, and management of diseases, spanning laboratory diagnostics, tissue diagnostics, and diabetes care. Roche is committed to personalized healthcare, pioneering the development of targeted therapies and companion diagnostics that enable treatment decisions tailored to individual patients. The compaRead more
Roche Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Roche your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Roche has new funding data
Website visits: Recent activity has been detected on your website
Roche, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Roche had a recent Job posting/layoffs
Check if Roche has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Roche launches new products
Earning: See what the market has to say on Roche recently announced quarterly report
Check out if Roche is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Roche
Recommended Actions
Reach out to Masked Content who joined Roche as Masked Content
Find 3 more new buyers
Explore company insights
Get a deeper look into Roche's structure, leadership, and market position:
Company Profile Activity
Activity Insights
Roche is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Roche is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Roche.
Roche Tech Stack
A closer look at the technologies used by Roche
Most Recent Scoops
Partnership
Partnership, Analytics & Insights, Research & Development, Business Development, Workforce Management, Laboratory Operations, Healthcare Operations, Healthcare Technology, Medical Administration
Earnings
Roche has reported that its top brands Xolair, Hem Libra, Ocrevus, Phesgo, Vabizmo, and Evrysdi collectively generated approximately 1.4 billion Swiss Francs in incremental sales at constant exchange rates in the first half of the year.
Earnings
Roche has provided a HER2 franchise outlook projecting peak sales of approximately 9 billion Swiss Francs (at 2024 constant exchange rates) in 2026, followed by a steady decline to a tail of approximately 4 billion, primarily from Phesgo, with no biosimilar for Perjeta expected in the US before 2028 or the EU before 2027.
Earnings, Finance
Earnings
Roche has reported hematology franchise sales of 4.6 billion Swiss Francs for the first half, growing 14% at constant exchange rates, with Hem Libra delivering strong global growth driven by increasing adoption in non-inhibitor patients and older adults, and has updated its full-year Hem Libra growth outlook to mid single digit from previously low single digit.
Earnings, Finance
Project
Medical Research, Pharmaceuticals, Clinical Operations
Roche News & Media
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
The PATHWAY HER2 (4B5) test and VENTANA HER2 Dual ISH DNA Probe Cocktail help identify HER2-positive metastatic gastric, gastroesophageal junction and esophageal adenocarcinoma. Differential diagnosis of these cancers, often aggressive and diagnosed at an advanced stage, is critical to...Roche receives FDA clearance for Elecsys® pTau217, advancing Alzheimer's disease assessment across primary and specialty care
First and only FDA-cleared, single-biomarker blood test supporting both rule-in and rule-out assessment of amyloid pathology across primary and specialty care settings The test delivers consistency across clinical settings by using the same validated cutoffs in primary and specialty care...Roche’s US subsidiary Genentech announces manufacturing expansion in the United States
Basel, 20 August 2026 - Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY) today announced plans to invest approximately $750 million in a new device fill-finish manufacturing facility at its 75-acre campus in Hillsboro, Oregon. The investment will bring new end-to-end device filling capabilities to the site and expand capacity to support the future pipeline of innovative medicines across Roche and Genentech.Roche expands cyclospora testing portfolio to support U.S. public health response
Roche has launched two new, real-time PCR tests to detect cyclospora, a diarrhea-causing infection, to help meet diverse needs of laboratories. The new tests expand the Roche cyclospora portfolio, providing laboratories with more flexible choices. Cyclospora tests are another example of...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Roche
Sign Up For FreeTo access detailed company insights
Roche is a global pioneer in pharmaceuticals and diagnostics, dedicated to advancing science to improve people's lives through innovative healthcare solutions. The Swiss-based company operates through two primary divisions: Pharmaceuticals and Diagnostics, making it one of the few healthcare companies with leading positions in both areas. Roche's p... Read More
